Controlled Substances and Pain Management: Regulatory Oversight, Formularies, and Cost Decisions

Journal of Law, Medicine and Ethics 24 (4):310-316 (1996)
  Copy   BIBTEX

Abstract

Pharmacists, physicians, and other health care personnel practice within an integrated system of laws and regulations that influence many treatment modalities. Capitation, managed care, and other controls strain these relationships by mandating greater oversight of how health care is delivered. From a pharmacists’s perspective, any use of medication requites knowledge of three omnipresent factors: regulatory control, formularies, and economic decision making. My objective is to raise awareness of these issues as they relate to the prescription of pain medication and to pain management generally.All practice-oriented drug law and regulation is based on the federal Controlled Substances Act of 1970. The Act, also known as Title II, is part of a much larger piece of legislation, the Comprehensive Drug Abuse Prevention and Control Act of 1970. CSA was enacted to regulate the manufacturing, distribution, dispensing, and delivery of drugs or substances that are subject to, or have the potential for, abuse or physical or psychological dependence.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,783

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Legal Issues in the Use of Controlled Substances in Pain Management.Jd Sandra Johnson - 2005 - Lahey Clinic Medical Ethics Journal 12 (1):4-12.
Organization of company cost management.G. A. Kononova & V. V. Tsiganov - 2013 - Liberal Arts in Russia 2 (3):285--292.
Medical Marijuana 2010: It's Time to Fix the Regulatory Vacuum.Peter J. Cohen - 2010 - Journal of Law, Medicine and Ethics 38 (3):654-666.
Pain: no medical necessity defense for marijuana to controlled substances act.Aviva Halpern - 2000 - Journal of Law, Medicine and Ethics 29 (3-4):410-411.
Regulatory Review and Cost-Benefit Analysis.Mark Sagoff - 2009 - Philosophy & Public Policy Quarterly 29 (3/4):21.
Gender differences: Implications for pain management.Ursula Wesselmann - 1997 - Behavioral and Brain Sciences 20 (3):470-471.
Introduction: Legal and Regulatory Issues in Pain Management.Sandra H. Johnson - 1998 - Journal of Law, Medicine and Ethics 26 (4):265-266.
Pain Management: Texas Legislative and Regulatory Update.David L. Ralston - 1996 - Journal of Law, Medicine and Ethics 24 (4):328-337.

Analytics

Added to PP
2016-02-04

Downloads
18 (#829,320)

6 months
6 (#510,793)

Historical graph of downloads
How can I increase my downloads?

References found in this work

No references found.

Add more references